Possible scenario
Competition Narrative Builds
20% Chance
Investors increasingly link Intuitive's share decline to rising competitive pressure from Johnson & Johnson's Ottava clearance and Stryker's investment in CMR Surgical. Even if Intuitive's current demand remains strong, the market discounts future share and pricing risks.
Secondary impacts
- Healthcare +0.2%
Tickers
- ISRG-2.8%
- JNJ+1.1%
- SYK+0.9%
Portfolio impact
S&P 500+0.0%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.